Skip to content

Anaptysbio, Inc.

ANAB Nasdaq SEC CIK 1370053

Follow Anaptysbio Weekly email: filings, results, news

News

4 stories filed under Anaptysbio

Earnings

Thread · 2 stories

AnaptysBio earnings on deck: Can Jemperli offset revenue slide?

Earnings 25 d ago 3 sources

AnaptysBio earnings ahead: First results as royalty company

Earnings 39 d ago 3 sources

More coverage

AnaptysBio stock rating maintained at Outperform by Wolfe Research

Markets 24 d ago 2 sources

GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control

Deals 38 d ago also on GSK

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 4 stories clustered from the RSS aggregator